Ht-Logo-gigapixel-icon
  • Menu
Search
Close this search box.
  • News
  • Opinion
  • Archives
  • Politics
  • Foreign Policy
  • Lobbying
  • Legislation
  • Policy
  • Hill Life & People
  • Podcast
  • News
  • Opinion
  • Archives
  • Politics
  • Foreign Policy
  • Lobbying
  • Legislation
  • Policy
  • Hill Life & People
  • Podcast
  • Get free News Updates
  • SIGN IN
  • SUBSCRIBE
  • Get free News Updates
  • SIGN IN
  • SUBSCRIBE
  • Get free News Updates
  • {email}
    • Administration
    • Account Settings
    • Logout
  • SUBSCRIBE
  • Get free News Updates
  • {email}
    • Administration
    • Account Settings
    • Logout
  • SUBSCRIBE
Ht-Logo-gigapixel-icon
  • Menu
Search
Close this search box.
  • Home Page
  • News
  • Opinion
  • Foreign Policy
  • Politics
  • Policy
  • Legislation
  • Lobbying
  • Hill Life & People
  • Hill Climbers
  • Heard On The Hill
  • Calendar
  • Archives
Menu
  • Home Page
  • News
  • Opinion
  • Foreign Policy
  • Politics
  • Policy
  • Legislation
  • Lobbying
  • Hill Life & People
  • Hill Climbers
  • Heard On The Hill
  • Calendar
  • Archives
My Account
  • Sign in
  • Sign in
  • Sign in
  • Sign in
Friday, December 8, 2023
Canada’s Politics and Government News Source Since 1989
Latest Paper
Friday, December 8, 2023 | Latest Paper
Subscribe Now

TRENDING:

  • House Speaker
  • AFN
  • Gerry Nicholls
  • Les Whittington
  • Former Parliamentarians
  • Liberal decline
  • Online News Act
  • House Speaker
  • AFN
  • Gerry Nicholls
  • Les Whittington
  • Former Parliamentarians
  • Liberal decline
  • Online News Act

Just price for drugs: the eleventh hour

For Canadians, it should be a reminder that we need to modernize our PMPRB watchdog to achieve 'just prices' and get rid of our irrational policies that serves corporate welfare to the detriment of patients.

Among all OECD countries, Canada ends up with the highest prices for patented drugs, behind the United States and Switzerland. We pay on average 25 per cent more on the price of patented drugs as compared to the median of OECD countries in the hope to attract investment in research and development (R&D), writes Marc-André Gagnon. Image courtesy of Pixabay
Opinion
BY MARC-ANDRé GAGNON
February 4, 2019
Opinion | BY MARC-ANDRé GAGNON | February 4, 2019

Sponsored content

How can Ontario achieve net zero, with greater energy reliability and resilience? Roadmap to a clean energy future

sponsored content
enb-new-photo

How can Ontario achieve net zero, with greater energy reliability and resilience? Roadmap to a clean energy future

Get The Weekend Point of View Newsletter

Top Canadian political and policy opinion and analysis. Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy

More Opinion

It’s time to unleash Canada’s energy advantage

Opinion

Language matters: measuring what you are versus what you are not

Opinion

The Federal Court decision to overturn the single-use plastic ban is a step backwards for the planet—and our health

OpinionBY BRAD LISKI

Is it better to talk about unity and not practise it, or not talk about it at all? 

OpinionBY ROSE LEMAY

Poilievre’s miscues won’t save Trudeau

OpinionBY GERRY NICHOLLS

Related Stories

Pharmacare in Canada: one step forward, two steps back

OpinionBY MARC-ANDRé GAGNON

PMPRB’s new regulations could be Canada’s monkey’s paw

Opinion

Don’t let the next pandemic meet this pharmaceutical sector

OpinionBY CHUKWUNONSO NWABUFO

Meanwhile, back in the pharma wars

OpinionBY LES WHITTINGTON

Will the government seek independent patient input on drug policy?

OpinionBY SHARON BATT

News

  • Politics
  • Foreign Policy
  • Lobbying
  • Legislation
  • Policy Briefings
  • Politics This Morning
  • Hill Climbers
  • Civil Circles
  • Heard On The Hill
  • Election
  • Finance and Budget
  • Public Service
  • Exclusive Lists
  • Parliamentary Calendar
  • Top 100 Lists and Exclusive Features
  • Podcasts
  • This Week's Paper
  • Search
  • Archives
  • Digital Newspaper Archives

Get free news updates

Opinion

  • Andrew Caddell
  • Sheila Copps
  • David Crane
  • Jim Creskey
  • Gwynne Dyer
  • Michael Harris
  • Erica Ifill
  • Scott Taylor
  • Joe Jordan
  • Rose LeMay
  • Alex Marland
  • Gerry Nicholls
  • Gar Pardy
  • Tim Powers
  • Susan Riley
  • Douglas Roche
  • Ken Rubin
  • Bhagwant Sandhu
  • Les Whittington

Submit a guest opinion article

resources

  • The Wire Report
  • Hill Times Research Health
  • The Lobby Monitor
  • Parliament Now
  • Inside Ottawa Directory
  • Hill Times Careers
  • The Hill Times Store
  • Digital Newspaper Archives

Advertise

  • Media Kit

subscribe

  • Group subscriptions
  • Reuse and permissions

get help

  • About us
  • Contact us
  • Privacy Policy
  • Reset Password
  • Account settings
  • © The Hill Times 2023
Subscribe
  • Home Page
  • News
  • Opinion
  • Foreign Policy
  • Politics
  • Policy
  • Legislation
  • Lobbying
  • Hill Life & People
  • Hill Climbers
  • Heard On The Hill
  • Calendar
  • Archives
  • Home Page
  • News
  • Opinion
  • Foreign Policy
  • Politics
  • Policy
  • Legislation
  • Lobbying
  • Hill Life & People
  • Hill Climbers
  • Heard On The Hill
  • Calendar
  • Archives
  • Inside Ottawa Directory
  • Hill Times Store
  • Hill Times Careers
  • The Wire Report
  • The Lobby Monitor
  • Parliament Now
  • Inside Ottawa Directory
  • Hill Times Store
  • Hill Times Careers
  • The Wire Report
  • The Lobby Monitor
  • Parliament Now
  • Reuse & Permissions
  • Advertising
  • Reuse & Permissions
  • Advertising
  • Contact Us
  • Log In
  • Logout
  • Contact Us
  • Log In
  • Logout
CloseMenu
  • {email}
  • Account Settings
  • Logout
  • {email}
  • Account Settings
  • Logout